Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | ACP3 | P15309 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4430667 | 0.83 | ESR1 (0.54) | ESR1ACHETSHRALDH1A1ACP3 | |
| SCHEMBL16308863 | 0.81 | ESR1 (0.52) | ESR1ACHETSHRALDH1A1ACP3 | |
| SCHEMBL16308826 | 0.81 | ESR1 (0.52) | ESR1ACHETSHRALDH1A1ACP3 | |
| SCHEMBL30647211 | 0.81 | ESR1 (0.52) | ESR1ACHETSHRALDH1A1ACP3 | |
| SCHEMBL29403593 | 0.81 | ESR1 (0.52) | ESR1ACHETSHRALDH1A1ACP3 | |
| SCHEMBL624799 | 0.81 | ESR1 (0.52) | ESR1ACHETSHRALDH1A1ACP3 | |
| SCHEMBL4537404 | 0.80 | ESR1 (0.41) | ESR1ACHETSHRALDH1A1GAA | |
| SCHEMBL6351769 | 0.79 | ESR1 (0.50) | ESR1ACHETSHRALDH1A1ACP3 | |
| SCHEMBL806254 | 0.79 | ESR1 (0.50) | ESR1ACHETSHRALDH1A1ACP3 | |
| SCHEMBL655520 | 0.78 | CYP1A2 (0.43) | ESR1TSHRALDH1A1SLC6A2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113999261-B | O-dimethyl aromatic ring type diphosphine ligand compound and synthesis method thereof | 浙江大学 | 2023-06-06 | — | — | CN | claimed |
| EP-2627172-A1 | AN ANTIMICROBIAL COMPOSITION | Agency For Science, Technology And Research (SG) | 2013-08-21 | — | — | EP | claimed |
| US-20130210881-A1 | ANTIMICROBIAL COMPOSITION | AGENCY FOR SCIENCE ,TECHNOLOGY AND RESEARCH (SG) | 2013-08-15 | — | — | US | claimed |
| WO-2012050531-A1 | AN ANTIMICROBIAL COMPOSITION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-04-19 | — | — | WO | claimed |
| EP-0242709-A2 | Antagonists of specific excitatory amino acid neurotransmitter receptors | NOVA PHARMACEUTICAL CORPORATION (US) | 1987-10-28 | — | — | EP | claimed |
| JP-2311475-A | — | — | None | — | — | JP | disclosed |
| CN-121045338-B | Cyclic peptide targeting CAIX and preparation method and application thereof | 原子高科股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-119630790-A | Novel LRP1 binding peptides | 一丸自然美健有限公司 | 2025-03-14 | — | — | CN | disclosed |
| WO-2024243639-A1 | AUTOPHAGY-INDUCING PEPTIDES | THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH (AU) | 2024-12-05 | — | — | WO | disclosed |
| CN-118995087-A | Adhesive film and dicing film-die bonding film | 株式会社力森诺科 | 2024-11-22 | — | — | CN | disclosed |
| CN-117940478-A | Phenol resin, epoxy resin, curable resin composition, cured product, fiber-reinforced composite material, and fiber-reinforced resin molded article | DIC株式会社 | 2024-04-26 | — | — | CN | disclosed |
| CN-117718084-A | Grafted and hyperbranched mixed anion exchangers | 戴安公司 | 2024-03-19 | — | — | CN | disclosed |
| US-4333932-A | DIHYDROISOINDOLES, HYPOGLYCEMIC, ANTIDIABETIC | PFIZER INC. (US) | 1982-06-08 | — | — | US | disclosed |
| EP-0010896-B1 | ORGANIC DIAMINE COMPOUNDS FOR USE AS ORAL HYPOGLYCEMIC AGENTS AND PHARMACEUTICAL COMPOSITIONS THEREOF | PFIZER INC. (US) | 1981-12-30 | — | — | EP | disclosed |
| US-4291114-A | COMPRISING A PHOTOPOLYMERIZABLE LAYER OF A MONOMER AND A CATIONIC PROMOTER ON AN OLEOPHILIC SURFACE OF A COVERING | MINNESOTA MINING AND MANUFACTURING CO. (US) | 1981-09-22 | — | — | US | disclosed |
| EP-0035530-A1 | IMAGEABLE, COMPOSITE DRY-TRANSFER SHEET. | MINNESOTA MINING & MFG (US) | 1981-09-16 | — | — | EP | disclosed |
| WO-1981000627-A1 | IMAGEABLE,COMPOSITE DRY-TRANSFER SHEET | MINNESOTA MINING & MFG (US) | 1981-03-05 | — | — | WO | disclosed |
| US-4220650-A | HYPOGLYCEMIC | PFIZER INC. (US) | 1980-09-02 | — | — | US | disclosed |
| US-4219648-A | 7-[[Amino(1,3-dihydrobenzo[c]thienyl)acetyl]amino]cephalosporin derivatives | RICHARDSON-MERRELL INC. (US) | 1980-08-26 | — | — | US | disclosed |
| US-4178293-A | Isoindolinyl derivatives | ZOECON CORPORATION (US) | 1979-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130210881-A1 | ANTIMICROBIAL COMPOSITION | NOD2, MPO, NACA | ESR1 4312/4885ACHE 3877/4885TSHR 4102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.